{
  "id": "df7593ecba4b00ae",
  "title": "Mesoblast Shares Flat Despite FDA Clarity on Path for Therapy Approval",
  "description": "20260120T111500Z",
  "content": "",
  "source": "thebull.com.au",
  "source_url": "https://thebull.com.au/news/mesoblast-shares-flat-despite-fda-clarity-on-path-for-therapy-approval/",
  "published_at": "20260120T111500Z",
  "fetched_at": "2026-01-21T00:24:36.527019+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Australia",
  "raw_data": {
    "url": "https://thebull.com.au/news/mesoblast-shares-flat-despite-fda-clarity-on-path-for-therapy-approval/",
    "url_mobile": "",
    "title": "Mesoblast Shares Flat Despite FDA Clarity on Path for Therapy Approval",
    "seendate": "20260120T111500Z",
    "socialimage": "",
    "domain": "thebull.com.au",
    "language": "English",
    "sourcecountry": "Australia"
  }
}